Search

everythinglearnresearchcommunity

for

Search:↓

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

New methods are being developed to improve drug delivery to the brain.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The model can help predict how finasteride and minoxidil work when applied to the scalp.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

The two finasteride tablet formulations are bioequivalent.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Formulation F1 is the best for delivering finasteride effectively.

Photobiomodulation therapy is beneficial in plastic surgery and dermatology.

Researchers developed a method to measure drugs in hair follicles and found that both water-loving and fat-loving drugs can be detected after being applied to the skin.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Numerical methods help analyze alopecia drugs' properties effectively.

The test and reference finasteride tablets are bioequivalent.

Hair follicles are promising targets for delivering drugs effectively.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

A new system was created to classify skin changes in cancer patients based on their treatment.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Combining nanotechnology with herbal medicine may improve PCOS treatment.